Clinical Trial
Clinical experience with vaccines produced in the human diploid cell line WI-38
- PMID: 4976367
Item in Clipboard
Clinical Trial
Clinical experience with vaccines produced in the human diploid cell line WI-38
Natl Cancer Inst Monogr.
1968 Dec.
No abstract available
Similar articles
-
Vaccines produced in diploid cell lines.Natl Cancer Inst Monogr. 1968 Dec;29:485-93. Natl Cancer Inst Monogr. 1968. PMID: 4976866 Clinical Trial. No abstract available.
-
Vaccines produced in heteroploid cell lines--discussion.Natl Cancer Inst Monogr. 1968 Dec;29:471-2. Natl Cancer Inst Monogr. 1968. PMID: 4976366 Clinical Trial. No abstract available.
-
Karyologic characteristics of the WI-38 diploid cell system--general comments.Natl Cancer Inst Monogr. 1968 Dec;29:97-104. Natl Cancer Inst Monogr. 1968. PMID: 5720816 No abstract available.
-
Characteristics of primary cultures and diploid cells--technology of production.Natl Cancer Inst Monogr. 1968 Dec;29:21-31. Natl Cancer Inst Monogr. 1968. PMID: 4976359 Review. No abstract available.
-
Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.Natl Cancer Inst Monogr. 1968 Dec;29:241-68. Natl Cancer Inst Monogr. 1968. PMID: 4306757 Review. No abstract available.